BeyondSpring Inc. Increase (Decrease) in Other Operating Liabilities
BeyondSpring Inc. (BYSI) reported Increase (Decrease) in Other Operating Liabilities of -$1.84 million for the 3-month period ending 2021-03-31, per its 6-K filed 2021-06-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2021-06-16
- BeyondSpring Inc. increase (decrease) in other operating liabilities for the quarter ending 2021-03-31 was -$1.84M, a 409.23% decline year-over-year.
- BeyondSpring Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-12-31 was $1.87M.
- BeyondSpring Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was $567.00K.
- BeyondSpring Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-06-30 was -$661.00K, a 192.84% decline year-over-year.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$1.84M 6-K · filed 2021-06-16 | $27.00K derived: sum of 2 quarters · filed 2021-06-16 | $594.00K derived: sum of 3 quarters · filed 2021-06-16 | -$67.00K derived: sum of 4 quarters · filed 2021-06-16 |
| 2020-12-31 | $1.87M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $2.44M derived: sum of 2 quarters · filed 2021-04-30 | $1.78M derived: sum of 3 quarters · filed 2021-04-30 | $2.37M 20-F · filed 2021-04-30 |
| 2020-09-30 | $567.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | -$94.00K derived: sum of 2 quarters · filed 2020-11-17 | $502.00K 6-K · filed 2020-11-17 | $184.00K derived: sum of 4 quarters · filed 2021-06-16 |
| 2020-06-30 | -$661.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-09-03 | -$65.00K 6-K · filed 2020-09-03 | -$383.00K derived: sum of 3 quarters · filed 2021-06-16 | -$1.28M derived: sum of 4 quarters · filed 2021-06-16 |
| 2020-03-31 | $596.00K 6-K · filed 2021-06-16 | $278.00K derived: sum of 2 quarters · filed 2021-06-16 | -$623.00K derived: sum of 3 quarters · filed 2021-06-16 | $89.00K derived: sum of 4 quarters · filed 2021-06-16 |
| 2019-12-31 | -$318.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | -$1.22M derived: sum of 2 quarters · filed 2021-04-30 | -$507.00K derived: sum of 3 quarters · filed 2021-04-30 | -$275.00K 20-F · filed 2021-04-30 |
| 2019-09-30 | -$901.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | -$189.00K derived: sum of 2 quarters · filed 2020-11-17 | $43.00K 6-K · filed 2020-11-17 | $1.04M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-06-30 | $712.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-09-03 | $944.00K 6-K · filed 2020-09-03 | $1.94M derived: sum of 3 quarters · filed 2021-04-30 | $1.84M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-03-31 | $232.00K 6-K · filed 2020-06-11 | $1.23M derived: sum of 2 quarters · filed 2021-04-30 | $1.13M derived: sum of 3 quarters · filed 2021-04-30 | $1.29M derived: sum of 4 quarters · filed 2021-04-30 |
| 2018-12-31 | $993.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $894.00K derived: sum of 2 quarters · filed 2021-04-30 | $1.06M derived: sum of 3 quarters · filed 2021-04-30 | $1.06M 20-F · filed 2021-04-30 |
| 2018-09-30 | -$99.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | $70.00K derived: sum of 2 quarters · filed 2019-12-18 | $72.00K 6-K · filed 2019-12-18 | -$61.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-06-30 | $169.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | $171.00K 6-K · filed 2019-09-18 | $38.00K derived: sum of 3 quarters · filed 2020-04-30 | $169.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-03-31 | $2.00K 6-K · filed 2019-07-10 | -$131.00K derived: sum of 2 quarters · filed 2020-04-30 | $0.00 derived: sum of 3 quarters · filed 2020-04-30 | $142.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2017-12-31 | -$133.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -$2.00K derived: sum of 2 quarters · filed 2020-04-30 | $140.00K derived: sum of 3 quarters · filed 2020-04-30 | $64.00K 20-F · filed 2020-04-30 |
| 2017-09-30 | $131.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $273.00K derived: sum of 2 quarters · filed 2018-10-23 | $197.00K 6-K · filed 2017-11-09 | $340.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-06-30 | $142.00K derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | $66.00K 6-K · filed 2018-10-23 | $209.00K derived: sum of 3 quarters · filed 2019-04-30 | $270.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-03-31 | -$76.00K 6-K · filed 2018-06-21 | $67.00K derived: sum of 2 quarters · filed 2019-04-30 | $128.00K derived: sum of 3 quarters · filed 2019-04-30 | $97.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2016-12-31 | $143.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $204.00K derived: sum of 2 quarters · filed 2019-04-30 | $173.00K derived: sum of 3 quarters · filed 2019-04-30 | $174.00K 20-F · filed 2019-04-30 |
| 2016-09-30 | $61.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $30.00K derived: sum of 2 quarters · filed 2017-11-09 | $31.00K 6-K · filed 2017-11-09 | |
| 2016-06-30 | -$31.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | -$30.00K 6-K · filed 2017-08-21 | ||
| 2016-03-31 | $1.00K 6-K · filed 2017-05-22 | |||
| 2015-12-31 | $14.00K 20-F · filed 2018-04-03 | |||
| 2014-12-31 | $47.00K 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |